ERJ Podcast
Eur Respir J 2011; 37: E2 | |
Titanium and gold nanoparticles in asthma: the bad and the ugly Lanone S., Boczkowski J. Eur Respir J 2011; 37: 225 | |
The promise of electronic data capture in respiratory medicine Johnston N., O'Byrne P., Kolb M. Eur Respir J 2011; 37: 228 | |
Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography Lofaso F., Fauroux B., Orlikowski D., Prigent H. Eur Respir J 2011; 37: 231 | |
The case for inspiratory muscle training in COPD Ambrosino N. Eur Respir J 2011; 37: 233 | |
The case against inspiratory muscle training in COPD Polkey M.I., Moxham J., Green M. Eur Respir J 2011; 37: 236 | |
Vitamin D status and longitudinal lung function decline in the Lung Health Study Kunisaki K.M., Niewoehner D.E., Singh R.J., Connett J.E. Eur Respir J 2011; 37: 238 | |
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways Cortijo J., Mata M., Milara J., Donet E., Gavaldà A., Miralpeix M., Morcillo E.J. Eur Respir J 2011; 37: 244 | |
Candidate genes for COPD in two large data sets Bakke P.S., Zhu G., Gulsvik A., Kong X., Agusti A.G.N., Calverley P.M.A., Donner C.F., Levy R.D., Make B.J., Paré P.D., Rennard S.I., Vestbo J., Wouters E.F.M., Anderson W., Lomas D.A., Silverman E.K., Pillai S.G. Eur Respir J 2011; 37: 255 | |
Symptom variability in patients with severe COPD: a pan-European cross-sectional study Kessler R., Partridge M.R., Miravitlles M., Cazzola M., Vogelmeier C., Leynaud D., Ostinelli J. Eur Respir J 2011; 37: 264 | |
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison Kornmann O., Dahl R., Centanni S., Dogra A., Owen R., Lassen C., Kramer B. Eur Respir J 2011; 37: 273 | |
Health-related quality of life and functional status in end-stage COPD: a longitudinal study Habraken J.M., van der Wal W.M., ter Riet G., Weersink E.J.M., Toben F., Bindels P.J.E. Eur Respir J 2011; 37: 280 | |
Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients Olloquequi J., Montes J.F., Prats A., Rodríguez E., Montero M.A., García-Valero J., Ferrer J. Eur Respir J 2011; 37: 289 | |
Lung exposure to nanoparticles modulates an asthmatic response in a mouse model Hussain S., Vanoirbeek J.A.J., Luyts K., De Vooght V., Verbeken E., Thomassen L.C.J., Martens J.A., Dinsdale D., Boland S., Marano F., Nemery B., Hoet P.H.M. Eur Respir J 2011; 37: 299 | |
A mobile telephone-based interactive self-care system improves asthma control Liu W-T., Huang C-D., Wang C-H., Lee K-Y., Lin S-M., Kuo H-P. Eur Respir J 2011; 37: 310 | |
Exercise is associated with improved asthma control in adults Dogra S., Kuk J.L., Baker J., Jamnik V. Eur Respir J 2011; 37: 318 | |
Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort Carlsten C., Brauer M., Dimich-Ward H., Dybuncio A., Becker A.B., Chan-Yeung M. Eur Respir J 2011; 37: 324 | |
Osteopontin expression and relation to disease severity in human asthma Samitas K., Zervas E., Vittorakis S., Semitekolou M., Alissafi T., Bossios A., Gogos H., Economidou E., Lötvall J., Xanthou G., Panoutsakopoulou V., Gaga M. Eur Respir J 2011; 37: 331 | |
Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma Schmitt L., Wiebel M., Frese F., Dehnert C., Zugck C., Bärtsch P., Mairbäurl H. Eur Respir J 2011; 37: 342 | |
Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function Duong-Quy S., Dao P., Hua-Huy T., Guilluy C., Pacaud P., Dinh-Xuan A.T. Eur Respir J 2011; 37: 349 | |
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Song J.W., Hong S-B., Lim C-M., Koh Y., Kim D.S. Eur Respir J 2011; 37: 356 | |
Procedure volume is one determinant of centre effect in mechanically ventilated patients Darmon M., Azoulay E., Fulgencio J-P., Garrigues B., Gouzes C., Moine P., Villers D., Teboul V., le Gall J-R., Chevret S. Eur Respir J 2011; 37: 364 | |
Usefulness of serum procalcitonin levels in pulmonary tuberculosis Ugajin M., Miwa S., Shirai M., Ohba H., Eifuku T., Nakamura H., Suda T., Hayakawa H., Chida K. Eur Respir J 2011; 37: 371 | |
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Su W-J., Feng J-Y., Chiu Y-C., Huang S-F., Lee Y-C. Eur Respir J 2011; 37: 376 | |
Prognostic value of procalcitonin in community-acquired pneumonia Schuetz P., Suter-Widmer I., Chaudri A., Christ-Crain M., Zimmerli W., Mueller B. Eur Respir J 2011; 37: 384 | |
Factors associated with inflammatory cytokine patterns in community-acquired pneumonia Martínez R., Menéndez R., Reyes S., Polverino E., Cillóniz C., Martínez A., Esquinas C., Filella X., Ramírez P., Torres A. Eur Respir J 2011; 37: 393 | |
Screening for sleep-disordered breathing in neuromuscular disease using a questionnaire for symptoms associated with diaphragm paralysis Steier J., Jolley C.J., Seymour J., Teschler H., Luo Y.M., Polkey M.I., Moxham J. Eur Respir J 2011; 37: 400 | |
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils Langereis J.D., Oudijk E-J.D., Schweizer R.C., Lammers J-W.J., Koenderman L., Ulfman L.H. Eur Respir J 2011; 37: 406 | |
Impact of inspiratory muscle training in patients with COPD: what is the evidence? Gosselink R., De Vos J., van den Heuvel S.P., Segers J., Decramer M., Kwakkel G. Eur Respir J 2011; 37: 416 | |
Circulating endothelial progenitor cells and chronic pulmonary diseases Huertas A., Palange P. Eur Respir J 2011; 37: 426 | |
Assessment of problematic severe asthma in children Lødrup Carlsen K.C., Hedlin G., Bush A., Wennergren G., de Benedictis F.M., De Jongste J.C., Baraldi E., Pedroletti C., Barbato A., Malmström K., Pohunek P., Pedersen S., Piacentini G.L., Middelveld R.J.M., Carlsen K.H. Eur Respir J 2011; 37: 432 | |
Treatment of tuberculosis: update 2010 Yew W.W., Lange C., Leung C.C. Eur Respir J 2011; 37: 441 | |
Subsequent COPD and lung cancer in patients with autoimmune disease Hemminki K., Liu X., Ji J., Sundquist K., Sundquist J. Eur Respir J 2011; 37: 463 | |
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan Ishii H., Tazawa R., Kaneko C., Saraya T., Inoue Y., Hamano E., Kogure Y., Tomii K., Terada M., Takada T., Hojo M., Nishida A., Ichiwata T., Trapnell B.C., Goto H., Nakata K. Eur Respir J 2011; 37: 465 | |
Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Izquierdo-García J.L., Peces-Barba G., Heili S., Diaz R., Want E., Ruiz-Cabello J. Eur Respir J 2011; 37: 468 | |
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose Amrein K., Schilcher G., Fahrleitner-Pammer A. Eur Respir J 2011; 37: 470 | |
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension Lee W-T.N., Kirkham N., Johnson M.K., Lordan J.L., Fisher A.J., Peacock A.J. Eur Respir J 2011; 37: 472 | |
Liver toxicity of sitaxentan in pulmonary arterial hypertension Galiè N., Hoeper M.M., Gibbs J.S.R., Simonneau G. Eur Respir J 2011; 37: 475 | |
Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Aggarwal D., Mohapatra P.R. Eur Respir J 2011; 37: 476 | |
From the authors: Nishiyama O., Taniguchi H. Eur Respir J 2011; 37: 476 | |
Non-invasive Ventilation and Weaning: Principles and Practice Ambrosino N. Eur Respir J 2011; 37: 478 | |